Clinical Trial Update: Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis

View source ↗

Summary

This clinical trial update notes the completed study assessing the impact of MANNA's Medically Tailored Meal Program in patients with non-terminal cancer diagno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Snippet

Sponsor: Thomas Jefferson University | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Status: COMPLETED